Details of the Drug

General Information of Drug (ID: DMKMYS4)

Drug Name
NSC-281612
Synonyms Benzaldehyde dimethane sulfonate; Dimethane sulfonate; Methylene dimethane sulfonate; DMS-612
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C14H21NO7S2
Canonical SMILES
CC1=C(C=CC(=C1)N(CCOS(=O)(=O)C)CCOS(=O)(=O)C)C=O
InChI
1S/C14H21NO7S2/c1-12-10-14(5-4-13(12)11-16)15(6-8-21-23(2,17)18)7-9-22-24(3,19)20/h4-5,10-11H,6-9H2,1-3H3
InChIKey
CQVKMVQRSNNAGO-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
322931
CAS Number
56967-08-9
TTD ID
D0TJ3M

References

1 ClinicalTrials.gov (NCT00923520) A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies. U.S. NationalInstitutes of Health.